Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,336
Closed -$583K 173
2024
Q1
$583K Buy
9,336
+4,045
+76% +$242K 0.06% 437
2023
Q4
$296K Buy
+5,291
New +$264K 0.03% 501
2022
Q2
Sell
-16,450
Closed -$1.13M 664
2022
Q1
$1.13M Sell
16,450
-8,852
-35% -$631K 0.12% 296
2021
Q4
$2M Buy
+25,302
New +$2.12M 0.22% 182
2021
Q3
Sell
-4,030
Closed -$318K 586
2021
Q2
$318K Sell
4,030
-1,758
-30% -$135K 0.03% 476
2021
Q1
$436K Sell
5,788
-7,907
-58% -$580K 0.04% 459
2020
Q4
$901K Sell
13,695
-754
-5% -$44.1K 0.07% 362
2020
Q3
$780K Buy
+14,449
New +$794K 0.05% 415

Other funds holding ENOV

Duality Advisers's ENOV Position: Q2 2024 in Review

Duality Advisers sold out of Enovis (ENOV) in Q2 2024, closing a stake of 9,336 shares — an estimated $583K sold.

Duality Advisers first reported a position in ENOV in Q3 2020 and held it in 8 quarters. The position peaked at $2M in Q4 2021. 282 funds tracked by Wall St. Rank hold ENOV as of Q2 2024.

  • Duality Advisers reported no remaining Enovis position as of Q2 2024 after selling out during the quarter.
  • Duality Advisers sold 9,336 Enovis shares in Q2 2024, an estimated $583K.
  • Duality Advisers first reported a position in Enovis in Q3 2020 and held it in 8 quarters.
  • Duality Advisers's Enovis position peaked at $2M in Q4 2021.
  • 282 funds tracked by Wall St. Rank held Enovis as of Q2 2024.

Based on Duality Advisers's 13F filing for Q2 2024.